Page last updated: 2024-08-16

propafenone and cifenline

propafenone has been researched along with cifenline in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (28.57)	18.7374
1990's	9 (42.86)	18.2507
2000's	3 (14.29)	29.6817
2010's	3 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD	1
Lombardo, F; Obach, RS; Waters, NJ	1
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A	1
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Kato, R; Koide, M; Miyahara, T; Sotobata, I; Toyama, J; Ukai, M; Yasui, S; Yokota, M	1
Arnaud, R; Babuty, D; Bine-Scheck, F; Cosnay, P; Fauchier, JP; Rouesnel, P	1
Aupetit, JF; Faucon, G; Gerentes-Chassagne, I; Larbre, JP; Loufoua-Moundanga, J; Timour, Q	1
Aupetit, JF; Faucon, G; Gerentes-Chassagne, I; Kioueh, I; Loufoua-Moundanga, J; Timour, Q	1
Somberg, J	1
Baudouy, M; Camous, JP; Gibelin, P; Ichai, C; Meyer, P; Morand, P; Varenne, A	1
Touboul, P	1
Ino, T; Karagueuzian, HS; Mandel, WJ; Meesmann, M; Ohta, M; Peter, T; Sugi, K	1
Heger, JJ; Prystowsky, EN; Zipes, DP	1
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P	1
Lüderitz, B; Manz, M	1
Aupetit, JF; Faucon, G; Kioueh, I; Larbre, JP; Lopez, M; Loufoua-Moundanga, J; Timour, Q	1
Aouate, P; Benassar, A; Fontaine, G; Frank, R; Jacquemin, M; Laborde, JP; Tageddine, R; Tonet, J; Turlure, A	1
Bleinc, D; Canler, A; Lardoux, H; Maison Blanche, P; Marchand, X; Péraudeau, P; Rouesnel, P; Scheck, F	1
Beurrier, D; Brembilla-Perrot, B; Danchin, N; Houplon, P; Jacquemin, L; Louis, P; Terrier de la Chaise, A	1

Reviews

4 review(s) available for propafenone and cifenline

Article	Year
Antiarrhythmic drug therapy. Recent advances and current status. Cardiology, 1985, Volume: 72, Issue:5-6 Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil	1985
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol]. Annales de cardiologie et d'angeiologie, 1982, Volume: 31, Issue:7 Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide	1982
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy. European heart journal, 1993, Volume: 14 Suppl E Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil	1993
[Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications]. Archives des maladies du coeur et des vaisseaux, 1995, Volume: 88, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Imidazoles; Male; Middle Aged; Propafenone; Tachycardia, Supraventricular	1995

Trials

2 trial(s) available for propafenone and cifenline

Article	Year
[Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia]. Annales de cardiologie et d'angeiologie, 1992, Volume: 41, Issue:4 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Propafenone	1992
[Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Annales de cardiologie et d'angeiologie, 1996, Volume: 45, Issue:8 Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Propafenone; Recurrence; Tachycardia, Ectopic Atrial	1996

Article

Year

[Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia].

Annales de cardiologie et d'angeiologie, 1992, Volume: 41, Issue:4

Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Propafenone

1992

[Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].

Annales de cardiologie et d'angeiologie, 1996, Volume: 45, Issue:8

Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Propafenone; Recurrence; Tachycardia, Ectopic Atrial

1996

Other Studies

15 other study(ies) available for propafenone and cifenline

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents. Bioorganic & medicinal chemistry letters, 2004, Sep-20, Volume: 14, Issue:18 Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovascular research, 2011, Jul-01, Volume: 91, Issue:1 Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection	2011
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment. Journal of applied toxicology : JAT, 2012, Volume: 32, Issue:10 Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers	2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration]. Japanese circulation journal, 1992, Volume: 56 Suppl 5 Topics: Administration, Oral; Anti-Arrhythmia Agents; Aprindine; Flecainide; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone	1992
[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia]. Bulletin de l'Academie nationale de medecine, 1991, Volume: 175, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Disease Models, Animal; Flecainide; Imidazoles; Injections, Intravenous; Propafenone; Swine	1991
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ. Naunyn-Schmiedeberg's archives of pharmacology, 1991, Volume: 343, Issue:6 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Disease; Coronary Vessels; Female; Flecainide; Heart Conduction System; Heart Rate; Imidazoles; Male; Propafenone; Swine; Ventricular Fibrillation	1991
[Treatment of poisoning caused by new anti-arrhythmia agents (cibenzoline, flecainide and propafenone)]. Presse medicale (Paris, France : 1983), 1987, Dec-05, Volume: 16, Issue:41 Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Flecainide; Humans; Imidazoles; Lactates; Lactic Acid; Male; Middle Aged; Propafenone	1987
[New class I anti-arrhythmia agents]. La Revue du praticien, 1986, Nov-21, Volume: 36, Issue:53 Topics: Anti-Arrhythmia Agents; Bepridil; Flecainide; Humans; Imidazoles; Kinetics; Propafenone; Pyrrolidines	1986
The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. American heart journal, 1986, Volume: 112, Issue:6 Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Female; Heart Ventricles; Imidazoles; Male; Myocardial Infarction; Procainamide; Propafenone; Tachycardia	1986
Drug therapy of cardiac arrhythmias. Cardiology clinics, 1983, Volume: 1, Issue:2 Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide	1983
Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart. Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Female; Flecainide; Heart Conduction System; Heart Rate; Imidazoles; Male; Myocardial Ischemia; Propafenone; Swine	1993
[Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?]. Archives des maladies du coeur et des vaisseaux, 1997, Volume: 90, Issue:7 Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Disopyramide; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Imidazoles; Male; Middle Aged; Predictive Value of Tests; Propafenone; Quinidine; Risk Factors	1997